CBD(cyclophohamide,bortezomib,dexamethasone) induction followed by autologous stem cell transplantation for patients with newly diagnosed multiple myeloma
Latest Information Update: 04 Jun 2018
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 27 May 2018 Status changed from recruiting to completed.
- 24 Jan 2013 New trial record